Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;18(9):1418-22.
doi: 10.1038/nm.2901.

EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

Annelies Van Hoecke  1 , Lies Schoonaert, Robin Lemmens, Mieke Timmers, Kim A Staats, Angela S Laird, Elke Peeters, Thomas Philips, An Goris, Bénédicte Dubois, Peter M Andersen, Ammar Al-Chalabi, Vincent Thijs, Ann M Turnley, Paul W van Vught, Jan H Veldink, Orla Hardiman, Ludo Van Den Bosch, Paloma Gonzalez-Perez, Philip Van Damme, Robert H Brown Jr, Leonard H van den Berg, Wim Robberecht
Affiliations

EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans

Annelies Van Hoecke et al. Nat Med. 2012 Sep.

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons. Disease onset and progression are variable, with survival ranging from months to decades. Factors underlying this variability may represent targets for therapeutic intervention. Here, we have screened a zebrafish model of ALS and identified Epha4, a receptor in the ephrin axonal repellent system, as a modifier of the disease phenotype in fish, rodents and humans. Genetic as well as pharmacological inhibition of Epha4 signaling rescues the mutant SOD1 phenotype in zebrafish and increases survival in mouse and rat models of ALS. Motor neurons that are most vulnerable to degeneration in ALS express higher levels of Epha4, and neuromuscular re-innervation by axotomized motor neurons is inhibited by the presence of Epha4. In humans with ALS, EPHA4 expression inversely correlates with disease onset and survival, and loss-of-function mutations in EPHA4 are associated with long survival. Furthermore, we found that knockdown of Epha4 also rescues the axonopathy induced by expression of mutant TAR DNA-binding protein 43 (TDP-43), another protein causing familial ALS, and the axonopathy induced by knockdown of survival of motor neuron 1, a model for spinomuscular atrophy. This suggests that Epha4 generically modulates the vulnerability of (motor) neurons to axonal degeneration and may represent a new target for therapeutic intervention.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurophysiol. 1993 Apr;69(4):1160-70 - PubMed
    1. Neurobiol Aging. 2007 Dec;28(12):1795-809 - PubMed
    1. Nat Neurosci. 2005 Jan;8(1):85-92 - PubMed
    1. Science. 2003 Mar 21;299(5614):1889-92 - PubMed
    1. Science. 2008 Mar 21;319(5870):1668-72 - PubMed

Publication types

MeSH terms